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Neurotrophins comprise a family of structurally and
functionally related proteins that are critical for the de-
velopment and maintenance of cutaneous innervation.
They also ful¢ll multiple non-neurotrophic functions
in skin, including regulation of epidermal proliferation
and apoptosis, control of hair follicle development and
cycling, and melanogenesis. Numerous indications sug-
gest that neurotrophins play an important role in the
pathogenesis of a variety of autoimmune diseases. In
this review, we focus on the role of neurotrophins in
the pathogenesis of alopecia areata, an autoimmune dis-
order that a¡ects actively growing hair follicles. Recent
data suggest that neurotrophins and their receptors are
di¡erentially expressed among the subsets of immune
cells in alopecia areata-a¡ected skin. Experimental data
suggest that neurotrophins may regulate both the cyclic
activity of the hair follicle and the functions of immune
cells of in£ammatory in¢ltrates. Additional research is
required to bridge the gap between our current knowl-
edge of neurotrophin functions in skin a¡ected by alo-
pecia areata and our knowledge of their potential
clinical applications. Progress in this area of research
will hopefully lead to the development of multiple ap-
plications for neurotrophins and their agonists/antago-
nists in alopecia areata and other hair growth dis-
orders. Keywords: nerve growth factor/autoimmune disorder/
apoptosis. JID Symposium Proceedings 8:195 ^198, 2003
A
lopecia areata (AA) is an autoimmune disease of ac-
tively growing hair follicles that a¡ects about 2% of
new patients attending dermatology clinics in the
United States and Britain (Price, 1991; Shapiro and
Price, 1998). Histologically, it is characterized by
peribulbar in£ammatory in¢ltrate of predominantly CD4þ
and CD8þ T lymphocytes, macrophages, and Langerhans cells
that target follicular keratinocytes, melanocytes, dermal papilla
¢broblasts, and endothelial cells (McDonagh and Messenger,
1996; Shapiro and Price, 1998). It has been shown that in AA aber-
rant expression of HLA class I and II antigens occurs in keratino-
cytes of the proximal hair follicle epithelium (Messenger et al,
1985; Konig et al, 1997). This abnormal expression leads to auto-
immune attack by CD4þ T lymphocytes followed by develop-
ment of in£ammatory cell in¢ltration composed of CD4þ and
CD8þ cells, macrophages, and Langerhans cells (Gilhar et al,
1998; Ho¡mann, 1999). AA-a¡ected skin also shows increased
proin£ammatory TH1 and TH2 cytokines and upregulation of
CD28 and CD40L and their ligands (McElwee et al, 2002).
Proin£ammatory cytokines such as TNF-a, IL-1b, and IFN-g
stimulate aberrant expression of ICAM-1 and MHC class II mo-
lecules on other hair matrix keratinocytes and dermal papilla ¢-
broblasts (Messenger et al, 1985; Nickolo¡ and Gri⁄ths, 1991;
Tobin et al, 1991; van Baar et al, 1992; Konig et al, 1997). In contrast,
AA-resistant mice show upregulation of the counter-regulatory
molecules IL-4 and IL-10 (McElwee et al, 2002). Proin£amma-
tory cytokines lead to decrements in growth factor secretion by
dermal papilla ¢broblasts and result in premature catagen devel-
opment (Ho¡mann, 1999), which is characterized by abnormal
patterns of cell degeneration and apoptosis (Tobin et al, 1991;
Tobin, 1997). Dermal papilla ¢broblasts of AA-a¡ected hair folli-
cles are also characterized by high susceptibility to apoptotic cell
death in cell culture (Norris et al, 1995).
There are several indications in the literature suggesting that
severe psycho-emotional stress may cause the onset of AA (Thies,
1960; Hordinsky and Ericson, 1996). Immuno£uorescence studies
suggest that AA is characterized by profound changes in hair fol-
licles and skin innervation (Hordinsky et al, 1999; Hordinsky and
Ericson, 1996). Sensory neuropeptides and neurotransmitters re-
leased by sensory and autonomic nerve ¢bers that innervate the
skin can directly modulate hair cycle as well as immune cell func-
tion (reviewed in Ansel et al, 1997; Paus et al, 1997; Scholzen et al,
1998).
The maintenance and functions of sensory and autonomic
nerves in postnatal skin are regulated by locally produced neuro-
trophic factors that belong to di¡erent growth factor families
(neurotrophins and TGF-b/bone morphogenetic proteins; re-
viewed in Lewin and Barde, 1996; Bibel et al, 2000). In this re-
view, we focus on the neurotrophins and show their importance
for AA pathogenesis. Speci¢cally, we review the recent data illus-
trating a previously undiscovered role for neurotrophins in the
control of CD8 cell apoptosis in this disease.
NEUROTROPHINS,THEIR RECEPTORS, AND THE
CONTROL OF CELL SURVIVAL OR DEATH
The neurotrophin family consists of four proteins: nerve growth
factor (NGF), brain-derived neurotrophic factor (BDNF), neuro-
trophin-3 (NT-3), and neurotrophin-4 (NT-4). All four exert
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their biological e¡ects as dimers interacting with speci¢c recep-
tors (for review see Bothwell, 1995; Bothwell, 1997). High-a⁄nity
receptors for neurotrophins belong to the tyrosine kinase family:
TrkA is a high-a⁄nity receptor for NGF,TrkB is a high-a⁄nity
receptor for BDNF and NT-4, and TrkC is a high-a⁄nity recep-
tor for NT-3 (Fig 1).
The four neurotrophin proteins also bind to the p75 kDa neu-
rotrophin receptor (p75NTR), which is a member of the TNF
family of receptors containing the cytoplasmic ‘‘death’’domain in-
volved in mediating apoptosis (for review see Chao et al, 1998;
Miller and Kaplan, 2001). p75NTR signaling can mediate apop-
tosis only when Trk signaling is inactive or suboptimally acti-
vated, whereas Trk activation can silence p75NTR apoptotic
signaling. It was recently shown that activation of p75NTR
signaling by neurotrophins recruits a variety of intracellular
adaptor molecules (reviewed in Bibel et al, 2000; Miller and Ka-
plan, 2001; Fig 2). In particular, it was demonstrated in several
models that the JNK-p53-Bax pathway is involved in neurotro-
phin-induced apoptosis (Aloyz et al, 1998; Bamji et al, 1998). The
JNK family of stress-activated kinases has been shown to be
downstream of p75NTRwhereas MKK4/7 and Ask1 kinases act
upstream of JNK in p75NTR-mediated apoptosis (Miller and
Kaplan, 2001). Activation of the JNK pathway leads to upregula-
tion of p53 protein and to an increase in transcription of p53 tar-
get genes, including Bax (Miller and Kaplan, 2001). This results
in activation of cellular caspases, DNA fragmentation, and cell
death.
NEUROTROPHINS AND THE CONTROL OF HAIR
GROWTH CYCLE IN NORMAL SKIN
It is now well appreciated that, besides their involvement in the
control of neuronal development, neurotrophins ful¢ll multiple
non-neurotrophic functions and regulate cell proliferation, di¡er-
entiation, apoptosis, and tissue remodeling outside of the nervous
system (reviewed in Aloe et al, 1997; Pincelli andYaar, 1997). Neu-
rotrophins are intimately involved in the control of epidermal
homeostasis, and NGF stimulates keratinocyte proliferation and
supresses apoptosis in keratinocytes and melanocytes in vitro (re-
viewed in Pincelli, 1997). NGF also stimulates TrkA phosphoryla-
tion in keratinocytes and Trk-inhibitor alkaloid K252a suppresses
NGF-induced keratinocyte proliferation (Pincelli et al, 1997). As
was shown in transgenic and knockout models, BDNF, NT-3,
and NT-4 also stimulate keratinocyte proliferation in murine epi-
dermis (Botchkarev et al, 1999b).
We showed that neurotrophins play an important role in the
control of hair follicle cycling in normal C57BL/6 mice. During
the murine hair cycle, steady-state levels of NGF and NT-3 pro-
teins signi¢cantly £uctuate in a hair cycle-dependent manner:
NGF levels rose dramatically in early-anagen skin (Welker et al,
1996), but NT-3 was signi¢cantly upregulated during catagen
(Botchkarev et al, 1998). The steady-state levels of NT-3, BDNF,
and NT-4 mRNAs were also signi¢cantly increased prior to and
during catagen onset (Botchkarev et al, 1998; Botchkarev et al,
1999a). We further showed that neonatal transgenic mice that
overexpress NGF, NT-3, or BDNF display accelerated catagen
development, and that BDNF-overexpressing mice display a
signi¢cant shortening of hair length compared to corresponding
age-matched wild-type animals (Botchkarev et al, 1998; Botchkarev
et al, 1999a; Botchkarev et al, 2000). Conversely, neurotrophin (NT-
3, BDNF, and NT-4) null mutants show catagen retardation.
The addition of NT-3, NT-4, and BDNF in vitro signi¢cantly
stimulates catagen development in C57BL/6 murine skin organ
cultures, whereas the p75NTR antagonist cyclic decapeptide ab-
rogates the catagen-stimulatory e¡ects of neurotrophins and re-
tards catagen in situ (Botchkarev et al, 1999a; Botchkarev et al,
1998; Botchkarev et al, 2003). By using p75NTR knockout mice,
we showed that the catagen stimulatory e¡ects of neurotrophins
are mediated by their binding via p75NTR expressed in kerati-
nocytes of the regressing outer root sheath (Botchkarev et al,
2000a).
NEUROTROPHINS IN PATHOGENESIS OF
AUTOIMMUNE DISORDERS
There are numerous indications that neurotrophins play an im-
portant role in the pathogenesis of autoimmune diseases (cf. Aloe
and Tuveri, 1997; Aloe et al, 1997). A signi¢cant increase in basal
NGF levels was found in the synovium of patients a¡ected by
rheumatoid arthritis, in the cerebrospinal £uid of patients with
multiple sclerosis, in the plasma of patients a¡ected by lupus ery-
thematosus, and in the skin of patients with systemic scleroderma
(Aloe et al, 1992; Bracci-Laudiero et al, 1992; Bracci Laudiero et al,
1993; Tuveri et al, 1993). Human CD4þ lymphocytes (both TH1
and TH2 subclones) secrete a biologically active form of NGF
(Lambiase et al, 1997), and an increase in NGF immunoreactivity
Figure1. Ligand-receptor interactions in the neurotrophin family.
Figure 2. Apoptotic signaling cascade activated by neurotrophins
after binding to p75NTR.
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was found in experimentally induced in£ammatory cell in¢l-
trates in the lungs (Braun et al, 1998). Upregulation of neurotro-
phins and their receptors was also shown during in£ammation in
many experimental models (Donovan et al, 1995; Wakabayashi
et al, 1996; Dmitrieva et al, 1997), and production of BDNF was
recently demonstrated in activated human T cells, B cells, and
monocytes (Kerschensteiner et al, 1999).
Increasingly the data suggest that NGF plays a suppressive
role in the development of autoimmune response (Ransoho¡
and Trebst, 2000). It was recently shown that administration
of NGF-neutralizing antibodies exacerbates neuropathological
signs of experimentally induced autoimmune encephalomyelitis
(Micera et al, 2000). Conversely, mice treated with NGF by
i.p. injections following induction of experimental autoimmune
encephalomyelitis showed a delayed onset of disease and lower
clinical scores during the course of disease (Arredondo et al,
2001). Most important, a protective role for NGF against auto
immune encephalomyelitis is achieved via downregulating the
production of INF-g and upregulating the production of IL-
10that is, via switching the balance of T helper cell type 1 and
type 2 cytokines (Villoslada et al, 2000).Taken together, these data
suggest that neurotrophins may be important in protecting
against autoimmune disorders and in suppressing immune re-
sponse via downregulation of proin£ammatory cytokines and
upregulation of TH2 cytokines.
NEUROTROPHINS IN PATHOGENESIS OFALOPECIA
AREATA
We recently showed that, in C3H/HeJ mouse models for AA, cu-
taneous steady-state levels of neurotrophins determined by ELI-
SA remain as high as those seen in the control nona¡ected skin
AA (Botchkarev et al, 2000b). This is consistent with previous re-
ports that showed high levels of neurotrophins in other tissues
a¡ected by autoimmune disorders (Aloe et al, 1992; Bracci-Lau-
diero et al, 1992; Bracci Laudiero et al, 1993; Tuveri et al, 1993). In
C3H/HeJ mouse back skin, anagen hair follicles not a¡ected by
AA showed moderate expression of NGF, absence of BDNF,
and coexpression of Trk and p75NTR in the outer root sheath.
In the AA-a¡ected anagen hair follicles, the levels of NGF and
BDNF were elevated in the outer and inner root sheath, respec-
tively, and all Trk receptors were downregulated in the outer root
sheath. In contrast, the apoptotic receptor p75NTRwas upregu-
lated in the outer root sheath and was ectopically expressed in the
dermal papilla (Palkina et al, 2002).
We showed that neurotrophins were strongly expressed
in macrophages in the in£ammatory cell in¢ltrates around the
hair follicles. In the AA-a¡ected skin, numerous macrophages,
identi¢ed by MOMA-2 immunoreactivity, coexpressed TrkB,
while dermal dendritic NLDC145-immunoreactive cells were
also p75NTR-positive. Double immunolabeling showed that
CD8þ cells in the in£ammatory in¢ltrates also expressed
p75NTR, implicating involvement of neurotrophins in the con-
trol of apoptosis in CD8þ lymphocytes (Palkina et al, 2002).
The latter data were con¢rmed by FACS analysis showing that
45%^75% of CD8 cells isolated from the a¡ected skin expressed
p75NTR whereas no p75NTR was seen on CD4 cells and
macrophages (Palkina et al, 2002). NGF or BDNF administration
into AA-a¡ected skin was associated with a reduction (po0.01) in
the number of CD8 cells, which coexpressed p75NTR and
TUNEL. Conversely, treatment of AA-a¡ected mice with a
cyclic peptide that blocks signaling through p75NTR promi-
nently increased the number of CD8 cells in the skin. These data
suggest a previously unrecognized role for neurotrophins in
stimulating CD8 cell apoptosis in skin a¡ected by AA, and they
raise a possibility of exploring stimulators of neurotrophin
signaling through p75NTR for the treatment of autoimmune
hair loss.
CONCLUSIONS
During the last decade, tremendous progress has been achieved in
delineating the molecular structure and function of neurotro-
phins and their receptors. Although initially identi¢ed as growth
factors stimulating the development of the nervous system, neu-
rotrophins are now recognized as powerful regulators of tissue
remodeling and homeostasis. In normal skin, they are important
factors controlling innervation, hair follicle growth, epidermal
proliferation, and melanogenesis. Our recent data demonstrate
that, in AA-a¡ected skin, neurotrophins may play multiple roles
and are involved not only in hair cycle regulation but also in the
modulation functions of immune cells (Fig 3). Speci¢cally, they
may be closely involved in the control of CD8 lymphocyte num-
bers via stimulating apoptosis through p75NTR expressed on
these cells.
Additional research is required to bridge the gap between our
current knowledge of neurotrophin functions in skin and our
knowledge of their potential clinical applications. The progress
in this area of research will, we hope, lead to the development
of multiple uses for neurotrophins and their agonists/antagonists
in AA and other hair growth disorders.
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